Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Circulation ; 92(10): 2848-54, 1995 Nov 15.
Article de Anglais | MEDLINE | ID: mdl-7586251

RÉSUMÉ

BACKGROUND: Myoglobin and fatty acid-binding protein (FABP) each are useful as early biochemical markers of muscle injury. We studied whether the ratio of myoglobin over FABP in plasma can be used to distinguish myocardial from skeletal muscle injury. METHODS AND RESULTS: Myoglobin and FABP were assayed immunochemically in tissue samples of human heart and skeletal muscle and in serial plasma samples from 22 patients with acute myocardial infarction (AMI), from 9 patients undergoing aortic surgery (causing injury of skeletal muscles), and from 10 patients undergoing cardiac surgery. In human heart tissue, the myoglobin/FABP ratio was 4.5 and in skeletal muscles varied from 21 to 73. After AMI, the plasma concentrations of both proteins were elevated between approximately 1 and 15 to 20 hours after the onset of symptoms. In this period, the myoglobin/FABP ratio was constant both in subgroups of patients receiving and those not receiving thrombolytics and amounted to 5.3 +/- 1.2 (SD). In serum from aortic surgery patients, both proteins were elevated between 6 and 24 hours after surgery; the myoglobin/FABP ratio was 45 +/- 22 (SD), which is significantly different from plasma values in AMI patients (P < .001). In patients with cardiac surgery, the ratio increased from 11.3 +/- 4.7 to 32.1 +/- 13.6 (SD) during 24 hours after surgery, indicating more rapid release of protein from injured myocardium than from skeletal muscles. CONCLUSIONS: The ratio of the concentrations of myoglobin over FABP in plasma from patients with muscle injury reflects the ratio found in the affected tissue. Since this ratio is different between heart (4.5) and skeletal muscle (20 to 70), its assessment in plasma allows the discrimination between myocardial and skeletal muscle injury in humans.


Sujet(s)
Protéines de transport/sang , Acides gras/métabolisme , Muscles squelettiques/traumatismes , Protéine P2 myèline/sang , Infarctus du myocarde/diagnostic , Myoglobine/sang , Protéines tumorales , Protéines suppresseurs de tumeurs , Sujet âgé , Aorte abdominale/chirurgie , Protéines de transport/analyse , Études cas-témoins , Pontage aortocoronarien , Test ELISA , Protéine-7 de liaison aux acides gras , Protéines de liaison aux acides gras , Femelle , Fibrinolytiques/usage thérapeutique , Prothèse valvulaire cardiaque , Humains , Mâle , Adulte d'âge moyen , Muscles squelettiques/composition chimique , Protéine P2 myèline/analyse , Infarctus du myocarde/sang , Infarctus du myocarde/traitement médicamenteux , Myocarde/composition chimique , Myoglobine/analyse , Streptokinase/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...